Literature DB >> 14630252

Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense.

Frank Vicini, Douglas Arthur, Csaba Polgar, Robert Kuske.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14630252     DOI： 10.1016/s0360-3016(03)00814-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  5 in total

1.  Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer.

Authors:  Randall J Kimple; Nancy Klauber-DeMore; Cherie M Kuzmiak; Dag Pavic; Jun Lian; Chad A Livasy; WingKeung M Chiu; Dominic T Moore; Carolyn I Sartor; David W Ollila
Journal:  Ann Surg Oncol       Date:  2011-04       Impact factor: 5.344

Review 2.  Accelerated Partial Breast Irradiation (APBI): A review of available techniques.

Authors:  Christopher F Njeh; Mark W Saunders; Christian M Langton
Journal:  Radiat Oncol       Date:  2010-10-04       Impact factor: 3.481

Review 3.  Current status and perspectives of brachytherapy for breast cancer.

Authors:  Csaba Polgár; Tibor Major
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

4.  A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance.

Authors:  Yuki Otani; Takayuki Nose; Takushi Dokiya; Toshiaki Saeki; Yu Kumazaki; Shuuji Asahi; Iwao Tsukiyama; Ichirou Fukuda; Hiroshi Sekine; Naoto Shikama; Takao Takahashi; Ken Yoshida; Tadayuki Kotsuma; Norikazu Masuda; Eisaku Yoden; Kazutaka Nakashima; Taisei Matsumura; Shino Nakagawa; Seiji Tachiiri; Yoshio Moriguchi; Jun Itami; Masahiko Oguchi
Journal:  Radiat Oncol       Date:  2015-06-04       Impact factor: 3.481

5.  Implementation of Stereotactic Accelerated Partial Breast Irradiation Using Cyber-Knife - Technical Considerations and Early Experiences of a Phase II Clinical Study.

Authors:  Norbert Mészáros; Viktor Smanykó; Tibor Major; Gábor Stelczer; Levente Jánváry; Eszter Kovács; Bahéri Mária; Zoltán Zaka; Dávid Pukancsik; Zoltán Takácsi-Nagy; Csaba Polgár
Journal:  Pathol Oncol Res       Date:  2020-05-29       Impact factor: 3.201
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.